Kendra L. Gully

Statistics

Publications

Citations

5.9K

H-Index

Active since

2020

Affiliations

University of North Carolina at Chapel Hill(Current)

Gilead Sciences (United States)

University of North Carolina Health Care

Lung Institute

UNC Lineberger Comprehensive Cancer Center

Kendra L. Gully is an author at University of North Carolina at Chapel Hill specializing in infectious diseases, sars-cov-2 infection, and molecular virology.

ORCID

Publications per year

2020–2024

Publications

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · Nature · 2020 · 1.7K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Kenneth H. Dinnon, Sarah R. Leist, Alexandra Schäfer et al. · Nature · 2020 · 685 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +15

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

Sarah R. Leist, Kenneth H. Dinnon, Alexandra Schäfer et al. · Cell · 2020 · 671 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +11

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer et al. · Cell · 2020 · 580 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · Cell Reports · 2020 · 540 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

1–5 of 33